Skip to main content
Top
Published in: Archives of Gynecology and Obstetrics 1/2012

01-07-2012 | Gynecologic Oncology

Post-treatment follow-up procedures in cervical cancer patients previously treated with radiotherapy

Authors: Seiji Mabuchi, Fumiaki Isohashi, Shintaro Maruoka, Takeshi Hisamatsu, Tsuyoshi Takiuchi, Yasuo Yoshioka, Tadashi Kimura

Published in: Archives of Gynecology and Obstetrics | Issue 1/2012

Login to get access

Abstract

Purpose

We investigated the role of physical examination, CT scan, chest X-ray, and Pap smear in the routine follow-up program for cervical cancer patients previously treated with radiotherapy.

Methods

The records of women who had developed recurrent cervical cancer after radiotherapy were retrospectively reviewed. The optimal procedure for the detection of recurrence was evaluated according to the disease-free interval (DFI). Survival analysis was performed based on the Kaplan–Meier method and comparisons between groups were made using the log-rank test.

Results

A total of 146 recurrent cervical cancer patients were included in our database. The majority of recurrences were diagnosed either by symptoms, physical examination, or CT scan. The patients whose recurrent disease was detected by Pap smear, physical examination, or CT scan had a significantly longer survival than those detected by symptoms. When analyzed according to DFI, physical examination, and CT scan led to the detection of recurrence in patients with a DFI of 1–5 years. In contrast, chest X-ray and Pap smear only had a clinical impact on the diagnosis of recurrence in patients with a DFI of 1–2 years.

Conclusions

Chest X-ray and Pap smear can be routinely performed for the first 2 years after radiotherapy, but can be omitted or used sparingly thereafter.
Literature
2.
go back to reference Ajiki W, Tsukuma H, Oshima A (2004) Research Group for Population-based Cancer Registration in Japan. Cancer incidence and incidence rates in Japan in 1999: estimates based on data from 11 population-based cancer registries. Jpn J Clin Oncol 34:352–356PubMedCrossRef Ajiki W, Tsukuma H, Oshima A (2004) Research Group for Population-based Cancer Registration in Japan. Cancer incidence and incidence rates in Japan in 1999: estimates based on data from 11 population-based cancer registries. Jpn J Clin Oncol 34:352–356PubMedCrossRef
3.
go back to reference Landoni F, Maneo A, Colombo A, Placa F, Milani R, Perego P et al (1997) Randomised study of radical surgery versus radiotherapy for stage Ib–IIa cervical cancer. Lancet 350:535–540PubMedCrossRef Landoni F, Maneo A, Colombo A, Placa F, Milani R, Perego P et al (1997) Randomised study of radical surgery versus radiotherapy for stage Ib–IIa cervical cancer. Lancet 350:535–540PubMedCrossRef
4.
go back to reference Long HJ (2007) Management of metastatic cervical cancer: review of the literature. J Clin Oncol 25:2966–2974PubMedCrossRef Long HJ (2007) Management of metastatic cervical cancer: review of the literature. J Clin Oncol 25:2966–2974PubMedCrossRef
5.
go back to reference Kew FM, Roberts AP, Cruickshank DJ (2005) The role of routine follow-up after gynecological malignancy. Int J Gynecol Cancer 15:413–419PubMedCrossRef Kew FM, Roberts AP, Cruickshank DJ (2005) The role of routine follow-up after gynecological malignancy. Int J Gynecol Cancer 15:413–419PubMedCrossRef
6.
go back to reference Mabuchi S, Morishige K, Isohashi F, Yoshioka Y, Takeda T, Yamamoto T et al (2009) Postoperative concurrent nedaplatin-based chemoradiotherapy improves survival in early-stage cervical cancer patients with adverse risk factors. Gynecol Oncol 115:482–487PubMedCrossRef Mabuchi S, Morishige K, Isohashi F, Yoshioka Y, Takeda T, Yamamoto T et al (2009) Postoperative concurrent nedaplatin-based chemoradiotherapy improves survival in early-stage cervical cancer patients with adverse risk factors. Gynecol Oncol 115:482–487PubMedCrossRef
7.
go back to reference Mabuchi S, Ugaki H, Isohashi F, Yoshioka Y, Temma K, Yada-Hashimoto N et al (2010) Concurrent weekly nedaplatin, external beam radiotherapy and high-dose-rate brachytherapy in patients with FIGO stage IIIb cervical cancer: a comparison with a cohort treated by radiotherapy alone. Gynecol Obstet Invest 69:224–232PubMedCrossRef Mabuchi S, Ugaki H, Isohashi F, Yoshioka Y, Temma K, Yada-Hashimoto N et al (2010) Concurrent weekly nedaplatin, external beam radiotherapy and high-dose-rate brachytherapy in patients with FIGO stage IIIb cervical cancer: a comparison with a cohort treated by radiotherapy alone. Gynecol Obstet Invest 69:224–232PubMedCrossRef
9.
go back to reference Bodurka-Bevers D, Morris M, Eifel PJ, Levenback C, Bevers MW, Lucas KR et al (2000) Posttherapy surveillance of women with cervical cancer: an outcomes analysis. Gynecol Oncol 78:187–193PubMedCrossRef Bodurka-Bevers D, Morris M, Eifel PJ, Levenback C, Bevers MW, Lucas KR et al (2000) Posttherapy surveillance of women with cervical cancer: an outcomes analysis. Gynecol Oncol 78:187–193PubMedCrossRef
10.
go back to reference Samlal RA, Van Der Velden J, Van Eerden T, Schilthuis MS, Gonzalez Gonzalez D, Lammes FB (1998) Recurrent cervical carcinoma after radical hysterectomy: an analysis of clinical aspects and prognosis. Int J Gynecol Cancer 8:78–84PubMedCrossRef Samlal RA, Van Der Velden J, Van Eerden T, Schilthuis MS, Gonzalez Gonzalez D, Lammes FB (1998) Recurrent cervical carcinoma after radical hysterectomy: an analysis of clinical aspects and prognosis. Int J Gynecol Cancer 8:78–84PubMedCrossRef
11.
go back to reference Zola P, Fuso L, Mazzola S, Piovano E, Perotto S, Gadducci A et al (2007) Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis? An Italian multicenter retrospective analysis. Gynecol Oncol 107:S150–S154PubMedCrossRef Zola P, Fuso L, Mazzola S, Piovano E, Perotto S, Gadducci A et al (2007) Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis? An Italian multicenter retrospective analysis. Gynecol Oncol 107:S150–S154PubMedCrossRef
12.
go back to reference Krebs HB, Helmkamp BF, Sevin BU, Poliakoff SR, Nadji M, Averette HE (1982) Recurrent cancer of the cervix following radical hysterectomy and pelvic node dissection. Obstet Gynecol 59:422–427PubMed Krebs HB, Helmkamp BF, Sevin BU, Poliakoff SR, Nadji M, Averette HE (1982) Recurrent cancer of the cervix following radical hysterectomy and pelvic node dissection. Obstet Gynecol 59:422–427PubMed
13.
go back to reference Duyn A, Van Eijkeren M, Kenter G, Zwinderman K, Ansink A (2002) Recurrent cervical cancer: detection and prognosis. Acta Obstet Gynecol Scand 81:351–355PubMedCrossRef Duyn A, Van Eijkeren M, Kenter G, Zwinderman K, Ansink A (2002) Recurrent cervical cancer: detection and prognosis. Acta Obstet Gynecol Scand 81:351–355PubMedCrossRef
14.
go back to reference Lim KC, Howells RE, Evans AS (2004) The role of clinical follow up in early stage cervical cancer in South Wales. BJOG 111:1444–1448PubMedCrossRef Lim KC, Howells RE, Evans AS (2004) The role of clinical follow up in early stage cervical cancer in South Wales. BJOG 111:1444–1448PubMedCrossRef
15.
go back to reference Morice P, Deyrolle C, Rey A, Atallah D, Pautier P, Camatte S, Thoury A et al (2004) Value of routine follow-up procedures for patients with stage I/II cervical cancer treated with combined surgery–radiation therapy. Ann Oncol 15:218–223PubMedCrossRef Morice P, Deyrolle C, Rey A, Atallah D, Pautier P, Camatte S, Thoury A et al (2004) Value of routine follow-up procedures for patients with stage I/II cervical cancer treated with combined surgery–radiation therapy. Ann Oncol 15:218–223PubMedCrossRef
16.
go back to reference Sartori E, Pasinetti B, Carrara L, Gambino A, Odicino F, Pecorelli S (2007) Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients. Gynecol Oncol 107:S241–S247PubMedCrossRef Sartori E, Pasinetti B, Carrara L, Gambino A, Odicino F, Pecorelli S (2007) Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients. Gynecol Oncol 107:S241–S247PubMedCrossRef
17.
go back to reference ACOG practice bulletin (2002) Diagnosis and treatment of cervical carcinomas. Obstet Gynecol 99(5 Pt 1):855–867 ACOG practice bulletin (2002) Diagnosis and treatment of cervical carcinomas. Obstet Gynecol 99(5 Pt 1):855–867
19.
go back to reference Tangjitgamol S, Levenback CF, Beller U, Kavanagh JJ (2004) Role of surgical resection for lung, liver, and central nervous system metastases in patients with gynecological cancer: a literature review. Int J Gynecol Cancer 14:399–422PubMedCrossRef Tangjitgamol S, Levenback CF, Beller U, Kavanagh JJ (2004) Role of surgical resection for lung, liver, and central nervous system metastases in patients with gynecological cancer: a literature review. Int J Gynecol Cancer 14:399–422PubMedCrossRef
20.
21.
go back to reference Tewari KS, Monk BJ (2009) Recent achievements and future developments in advanced and recurrent cervical cancer: trials of the Gynecologic Oncology Group. Semin Oncol 36:170–180PubMedCrossRef Tewari KS, Monk BJ (2009) Recent achievements and future developments in advanced and recurrent cervical cancer: trials of the Gynecologic Oncology Group. Semin Oncol 36:170–180PubMedCrossRef
Metadata
Title
Post-treatment follow-up procedures in cervical cancer patients previously treated with radiotherapy
Authors
Seiji Mabuchi
Fumiaki Isohashi
Shintaro Maruoka
Takeshi Hisamatsu
Tsuyoshi Takiuchi
Yasuo Yoshioka
Tadashi Kimura
Publication date
01-07-2012
Publisher
Springer-Verlag
Published in
Archives of Gynecology and Obstetrics / Issue 1/2012
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-012-2235-4

Other articles of this Issue 1/2012

Archives of Gynecology and Obstetrics 1/2012 Go to the issue